Rbf Capital, LLC Chimerix Inc Transaction History

Rbf Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.72 $68,770 - $111,228	-29,900 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.33 - $3.63 $109,646 - $299,260	-82,441 Reduced 73.38%	29,900 $93,000
Q4 2019 Feb 13, 2020	SELL	$1.3 - $2.72 $2,470 - $5,168	-1,900 Reduced 1.66%	112,341 $228,000
Q2 2019 Aug 13, 2019	SELL	$2.05 - $4.32 $162,554 - $342,554	-79,295 Reduced 40.97%	114,241 $494,000
Q1 2019 May 15, 2019	SELL	$1.79 - $3.12 $503,065 - $876,851	-281,042 Reduced 59.22%	193,536 $406,000

Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $1.06 Million - $1.85 Million	474,578 New	474,578 $1.22 Million

29.6M

18.9K

40.9K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Rbf Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Rbf Capital, LLC with notifications on news.